Health Trials

Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)

2

Review clinical trials related to Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

This study is a an open-label, multinational, multicenter, single-arm Phase Ⅰb/Ⅱ Study to Evaluate Efficacy and Safety of Oral HH2853 in Patients with Relapsed/Refractory Peripheral T-cell Lymphoma.

Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Haihe Biopharma Co., Ltd.Updated: Jan 30, 2026Locations: 1
Eligibility criteria

Tumor types and prior antitumor therapy: Phase Ib:Dose Escalation: All enrolled... [+4]

Previous treatment with EZH2 or EZH1/2 inhibitors. [+3]

Read more
Status: Recruiting

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

This is a phase I/II clinical trial to evaluate the efficacy and safety of Golidocitinib combined with Pomalidomide for relapsed/refractory peripheral T-cell lymphoma.

Participants needed: 33
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Sun Yat-sen UniversityUpdated: Mar 4, 2025Locations: 1
Eligibility criteria

Patients must demonstrate a comprehensive understanding of the study protocol, v... [+8]

Presence of hemophagocytic syndrome. [+13]

Read more